• KOL
    • KOLs Community
    • Occupational
    • Occupational Asthma
    • Emil J Bardana
    • Emil J Bardana

      Emil J Bardana

      Oregon Health and Science University, Portland, Ore | Oregon Health and Science University, Portland, OR 97239, USA. | Division of Allergy and Clinical Immunology, Department ...

       

       

      KOL Resume for Emil J Bardana

      Year
      2008

      Oregon Health and Science University, Portland, Ore

      2004

      Oregon Health and Science University, Portland, OR 97239, USA.

      2003

      Division of Allergy and Clinical Immunology, Department of Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, OP34, Portland, OR 97239, USA

      Oregon Health & Sciences University, Portland, Oregon.

      2002

      Oregon Health and Sciences University, Division of Allergy and Clinical Immunology, 3181 Southwest, Sam Jackson Park Road, OP 34, Portland, OR 97201, USA.

      2001

      Division of Allergy and Clinical Immunology, Oregon Health Sciences University, Portland, Oregon.

      1999

      Division of Allergy and Clinical Immunology, Oregon Health Sciences University, Portland 97201-3098, USA.

      1997

      Division of Allergy and Clinical Immunology, Oregon Health Sciences University, 97201-3098, Portland, OR

      1995

      Department of Medicine, Oregon Health Sciences University, Portland.

      1993

      Department of Medicine, Division of Allergy and Clinical Immunology The Oregon Health Sciences University, Portland, Oregon

      1992

      Division of Allergy and Clinical Immunology, Oregon Health Sciences University, Portland 97201.

      1991

      Professor of Medicine and Head, Division of Allergy and Clinical Immunology, Oregon Health Sciences University, Portland, Oregon

      1990

      Oregon Health Sciences University, Division of Allergy and Clinical Immunology, Portland.

      1988

      Oregon Health Sciences University, Portland, Oregon, USA

      3181 S. W. Sam Jackson Park Road, 97201, Portland, OR

      1986

      J. B

      Oregon Health Sciences University, in Portland. He has evaluated numerous complaints of building sickness and is working to develop objective criteria for measuring its symptoms

      1985

      Division of Immunology, Allergy and Rheumatology, Oregon Health Sciences University, Portland, Ore. USA

      1984

      Oregon Health Sciences University, Portland, OR 97201, USA

      1983

      Portland, Oregon, USA

      1982

      From the Department of Medicine, Divisions of Nephrology and Immunology, and Department of Pathology, The Oregon Health Sciences University, Portland, Oreg.

      University of Oregon Health Sciences Center Portland, Oregon, U.S.A.

      1981

      and Health Sciences Center, University of Oregon, Portland, Oregon, United States

      Oregon Regional Primate Research Center, Beaverton, Oregon 97006, U.S.A..

      1980

      Division of Immunology, Allergy, and Rhematology Health Science Center, University of Oregon Portland, Oregon

      From the Veterans Administration Hospital, U.S.A.

      1979

      Univ. of Oregon Health Sciences Center, Portland, USA

      1978

      Division of Immunology, Allergy and Rheumatology, University of Oregon Health Sciences Centre, Portland, Oregon, USA

      1977

      Established Investigator of the American Heart Association La Jolla, California, USA

      Divisions of Vascular Surgery and Immunology and the Department of Diagnostic Radiology, University of Oregon Health Sciences Center, Portland, Oregon

      1976

      Department of Microbiology and Immunology and the Division of Immunology and Allergy, University of Oregon Health Sciences Center, Portland, Oreg.

      From the Division of Immunology, Allergy, and Rheumatology, University of Oregon Health Sciences Center Portland, Ore., USA

      1975

      Section of Allergy and Clinical Immunology, National Jewish Hospital and Research Center, Denver, Colorado, 80206 Division of Immunology and Allergy, University of Oregon Medical School, Portland, Oregon, 97201, USA

      Division of Immunology and Allergy, University of Oregon Medical School, Portland, Oregon 97201

      1974

      Division of Immunology and Allergy University of Oregon Medical School Portland, Oregon 97201

      Portland, Oregon USA

      1972

      From the National Jewish Hospital and Research Center Denver, Colo., USA

      1971

      Departments of Allergy and Clinical Immunology and Clinical Laboratories, National Jewish Hospital and Research Center, Denver, Colorado 80206

      1970

      Division of Immunology, Allergy and Infectious Diseases, University of Oregon Medical School, Portland, Ore.

      Research Fellow of the Allergy Foundation of America.

       

       

      Emil J Bardana: Influence Statistics

      Sample of concepts for which Emil J Bardana is among the top experts in the world.
      Concept World rank
      positive cultures trial #1
      aspergillus normal subjects #1
      dle mctd #1
      animal fish protein #1
      aspergillus proposed1 #1
      proposed1 aspergillus antibody2 #1
      patients immunological responsiveness #1
      fungal antigens immunity #1
      ammonium sulfate test #1
      8 occupational asthma #1
      classic allergens #1
      antinuclear antibody effects #1
      normal individuals binding #1
      aspergillus antibody2 #1
      mctd continental ancestry #1
      aeroirritation toxic #1
      7 11 workers #1
      systemic lupuslike disease #1
      variety pulmonary #1
      syndrome rads #1
      oral toxicosis #1
      symptomatic thrush #1
      immunodiffusion fungal antigens #1
      primates primates amino #1
      aspergillin serum concentrations #1
      pathologic hallmark vasculitis #1
      abpa serum igd #1
      species radial immunodiffusion #1
      individuals variety #1
      conidial antigens aspergillus #1
      neoplasia potential triad #1
      inhalational toxicity #1
      definite etiologic associations #1
      antibodies aspergilli #1
      radiolabeled mycelial #1
      disease process battery #1
      pulmonary colonization infection #1
      developed decrease #1
      candida antibody immunodiffusion #1
      triad natural evolution #1
      spectrum aspergillus antigens #1

       

      Prominent publications by Emil J Bardana

      KOL-Index: 10315

      The capacity of antibodies in 102 human sera to bind components of aspergilli was studied. Sera were from patients with pulmonary aspergillosis or a variety of other clinical disorders and from healthy individuals. The antigens employed were anionic mucopolysaccharide components derived from A. fumigatus and A. nidulans and were not precipitated by antibodies in either human or rabbit sera. The antigens were soluble in 10 per cent trichloroacetic add and 50 per cent saturated ammonium ...

      Known for Primary Interaction | Normal Persons | Antibodies Sera | Patients Aspergillosis | Antigens Fungal
      KOL-Index: 9788

      As summarized in Table 1, the literature consistently supports the hypothesis that allergic asthmatic patients have seasonal BHR changes that parallel allergen exposure. These seasonal changes appear to be preventable by treatment with corticosteroids (systemic, inhaled, or nasal), disodium cromoglycate, and immunotherapy. Studies have almost exclusively focused on pollens, though similar limited data exist for dust mites. Though the dust mite is a perennial allergen, mite levels are ...

      Known for Seasonal Variation | Perennial Rhinitis | Bronchial Hyperreactivity | Viral Infections | Dust Mite
      KOL-Index: 6734

      Antibody to DNA was measured before and after treatment of systemic lupus erythematosus (SLE) sera with bovine pancreatic deoxyribonuclease (DNase I). In 11 of 15 cases of SLE with active renal disease there was a significant increase in DNA-binding after DNase digestion, while no such increase was noted in inactive SLE, normal controls or in patients with nonlupus renal disease. The significant rise in DNA-binding after digestion indicated that DNA had bound in vivo to the anti-DNA in ...

      Known for Systemic Lupus | Dna Complexes | Erythematosus Sera | Renal Disease | Sle Nephritis
      KOL-Index: 6341

      Reactive airways dysfunction syndrome (RADS) is defined as the sudden onset of asthma following a high level exposure to a corrosive gas, vapor, or fume. This variant of occupational asthma continues to generate controversy regarding the criteria for its diagnosis. There is also some disagreement as to the likely prognosis with this disorder. Currently, the diagnosis requires the assumption of normal premorbid pulmonary physiology and absence of bronchial hyperreactivity. Criteria for ...

      Known for Reactive Airways | Dysfunction Syndrome | Occupational Asthma | Bronchial Hyperreactivity | Sudden Onset
      KOL-Index: 6208

      Occupational rhinitis is a common but generally underreported entity. Although it may occur alone, it is frequently associated with occupational asthma. Occupational asthma may have one of several presentations that are difficult to distinguish from non-work conditions. The respiratory tract acts as the final common pathway for all inhaled environmental pollutants, whether encountered in the home or at work. More than 200 chemicals have been incriminated as a cause of work-related ...

      Known for Occupational Asthma | Respiratory Tract | Rhinitis Common | Diagnosis Differential | Environmental Pollutants
      KOL-Index: 5457

      To determine the effects of phenytoin on serum immunoglobulins, complement, and antinuclear antibody conversion, a prospective, five-year longitudinal study was undertaken in 118 patients. Three major diagnostic groups were evaluated: 27 patients with idiopathic epilepsy, 50 with secondary epilepsy, and 41 with neuropathic syndromes without epilepsy. In addition, 83 normal volunteers were studied in a similar manner. Evaluations were performed prior to administration of phenytoin and at ...

      Known for Serum Iga | Idiopathic Epilepsy | Effects Phenytoin | Antinuclear Antibodies | 27 Patients
      KOL-Index: 5430

      Antigens from Mycobacterium bovis and Listeria monocytogenes bind to serums from normal rabbits as well as from those immunized with unrelated bacteria, especially intracellular parasites. Binding is to the Fab portion of immunoglobulin G and is immunologically specific.

      Known for Mycobacterium Bovis | Shared Antigens | Listeria Monocytogenes | Bacterial Species | Unrelated Bacteria
      KOL-Index: 5287

      The antigenicities of Mycobacterium bovis strain BCG and an isoniazid (INH) - resistant mutant were compared. Sonic extracts of heat-killed, washed bacteria were injected into rabbits, and antisera were produced (anti-BCG and anti-BCG-R). The sonic extracts were also subjected to ultracentrifugation, and test antigens were prepared from the resulting supernatants (BCG and BCG-R). The antigens were labeled with (131)I, and the antisera were tested for their capacity to bind (131)I-BCG and ...

      Known for Strain Bcg | Test Antigens | Mycobacterium Bovis | Inhibition Studies | Isoniazid Inh
      KOL-Index: 4976

      The experiments presented in this report describe the preparation of a radiolabeled antigen which can be used in the ammonium sulfate test to measure antibodies against aspergilli. The antigenic components were in the trichloroacetic acid (TCA)-soluble fraction from sonically disrupted aspergilli. The major radiolabeled ligand appeared to be an immunologically nonprecipitating anionic mucopolysaccharide which was insensitive to DNase or RNase, slightly sensitive to pepsin, and very ...

      Known for Primary Interaction | Bacterial Antigens | Genus Aspergillus | Antigen Antibody | Antibodies Fungal
      KOL-Index: 4945

      The respiratory flora of patients with cystic fibrosis (CF) frequently includes Aspergillus, and 30% of their serum samples have been observed to contain precipitating antibody to this fungus. Serum from 61 CF patients, 60 healthy persons, and three patients with CF and allergic bronchopulmonary aspergillosis was studied, using a quantitative assay for antibody to A fumigatus. Although CF patients had significantly higher levels of Aspergillus antibody, some antibody was found in all ...

      Known for Cystic Fibrosis | Fumigatus Patients | Immunoglobulin Infant | Aspergillus Antibody | Antibodies Fungal

      Key People For Occupational Asthma

      Top KOLs in the world
      #1
      André Cartier
      occupational asthma bronchial responsiveness psychiatric disorders
      #2
      Jean‐Luc Malo
      occupational asthma guar gum bronchial responsiveness
      #3
      Moira M W Chan‐Yeung
      hong kong occupational asthma british columbia
      #4
      Peter Sherwood Burge
      occupational asthma west midlands fluticasone propionate
      #5
      JeanLuc Malo
      occupational asthma bronchial responsiveness cold air
      #6
      Susan Mary Tarlo
      occupational asthma chronic cough respiratory symptoms

      Emil J Bardana:Expert Impact

      Concepts for whichEmil J Bardanahas direct influence:Occupational asthma,  Sick building syndrome,  Digital ischemia,  Myasthenia gravis,  Serum igd,  Autoimmune hemolytic anemia,  Aspergillus antibody,  Hand ischemia.

      Emil J Bardana:KOL impact

      Concepts related to the work of other authors for whichfor which Emil J Bardana has influence:Systemic lupus erythematosus,  Aspergillus fumigatus,  Immune complexes,  Cystic fibrosis,  Lupus nephritis,  Occupational asthma,  Sick building syndrome.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Oregon Health and Science University, Portland, Ore | Oregon Health and Science University, Portland, OR 97239, USA. | Division of Allergy and Clinical Immunology, Department of Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.